Taiwan · Delayed Price · Currency is TWD Excelsior Biopharma Statistics
Total Valuation
TPEX:6496 has a market cap or net worth of TWD 1.11 billion. The enterprise value is 1.53 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.53B |
Important Dates
The next estimated earnings date is Thursday, February 18, 2027.
| Earnings Date | Feb 18, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6496 has 46.58 million shares outstanding. The number of shares has increased by 0.60% in one year.
| Current Share Class | 46.58M |
| Shares Outstanding | 46.58M |
| Shares Change (YoY) | +0.60% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 32.00% |
| Owned by Institutions (%) | n/a |
| Float | 15.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.46 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.04 |
Financial Efficiency
Return on equity (ROE) is -24.55% and return on invested capital (ROIC) is -16.70%.
| Return on Equity (ROE) | -24.55% |
| Return on Assets (ROA) | -8.05% |
| Return on Invested Capital (ROIC) | -16.70% |
| Return on Capital Employed (ROCE) | -18.95% |
| Weighted Average Cost of Capital (WACC) | 2.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.76 |
Taxes
In the past 12 months, TPEX:6496 has paid 12.06 million in taxes.
| Income Tax | 12.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.33% in the last 52 weeks. The beta is -0.16, so TPEX:6496's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -17.33% |
| 50-Day Moving Average | 24.04 |
| 200-Day Moving Average | 25.50 |
| Relative Strength Index (RSI) | 52.44 |
| Average Volume (20 Days) | 32,248 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6496 had revenue of TWD 959.88 million and -184.70 million in losses. Loss per share was -3.98.
| Revenue | 959.88M |
| Gross Profit | 366.73M |
| Operating Income | -179.24M |
| Pretax Income | -172.64M |
| Net Income | -184.70M |
| EBITDA | -162.37M |
| EBIT | -179.24M |
| Loss Per Share | -3.98 |
Balance Sheet
The company has 117.87 million in cash and 532.45 million in debt, with a net cash position of -414.58 million or -8.90 per share.
| Cash & Cash Equivalents | 117.87M |
| Total Debt | 532.45M |
| Net Cash | -414.58M |
| Net Cash Per Share | -8.90 |
| Equity (Book Value) | 657.75M |
| Book Value Per Share | 14.25 |
| Working Capital | 216.57M |
Cash Flow
In the last 12 months, operating cash flow was -93.15 million and capital expenditures -8.29 million, giving a free cash flow of -101.44 million.
| Operating Cash Flow | -93.15M |
| Capital Expenditures | -8.29M |
| Depreciation & Amortization | 16.87M |
| Net Borrowing | 149.10M |
| Free Cash Flow | -101.44M |
| FCF Per Share | -2.18 |
Margins
Gross margin is 38.21%, with operating and profit margins of -18.67% and -19.24%.
| Gross Margin | 38.21% |
| Operating Margin | -18.67% |
| Pretax Margin | -17.99% |
| Profit Margin | -19.24% |
| EBITDA Margin | -16.92% |
| EBIT Margin | -18.67% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6496 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.60% |
| Shareholder Yield | -0.60% |
| Earnings Yield | -16.68% |
| FCF Yield | -9.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6496 has an Altman Z-Score of 1.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 3 |